Parameters assessed by PSMA PET/CT such as the SUVmax of the primary tumor, prostate total-lesion PSMA, and prostate PSMA tumor volume can correlate significantly with pretreatment prostate-specific antigen values as well as grading via Gleason score (49). Here, FOLH1 is linked to neoplasm.